Found: 113
Select item for more details and to access through your institution.
Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Book review.
- Published in:
- 1995
- By:
- Publication type:
- Book Review
Translational research and epithelial carcinogenesis: Molecular diagnostic assays now--molecular...
- Published in:
- 1995
- By:
- Publication type:
- Editorial
Occurrence of p53 Gene Abnormalities in Gastric Carcinoma Tumors and Cells Lines.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 13, p. 938
- By:
- Publication type:
- Article
BOOK REVIEWS.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 6, p. 524
- By:
- Publication type:
- Article
Expression of the Atrial Natriuretic Factor Gene in small Cell Lung Cancer Tumors and Tumor Cell Lines.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 4, p. 305
- By:
- Publication type:
- Article
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors.
- Published in:
- Journal of Pathology, 2018, v. 246, n. 4, p. 459, doi. 10.1002/path.5161
- By:
- Publication type:
- Article
FGF18 as a prognostic and therapeutic biomarker in ovarian cancer.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 10, p. 4435, doi. 10.1172/JCI70625
- By:
- Publication type:
- Article
The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies.
- Published in:
- Cancer & Metastasis Reviews, 2015, v. 34, n. 1, p. 75, doi. 10.1007/s10555-014-9546-9
- By:
- Publication type:
- Article
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28840-5
- By:
- Publication type:
- Article
Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer.
- Published in:
- International Journal of Cancer, 1989, v. 44, p. 32, doi. 10.1002/ijc.2910440709
- By:
- Publication type:
- Article
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
- Published in:
- Nature Genetics, 2013, v. 45, n. 4, p. 362, doi. 10.1038/ng.2564
- By:
- Publication type:
- Article
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
- Published in:
- Nature Genetics, 2010, v. 42, n. 10, p. 874, doi. 10.1038/ng.668
- By:
- Publication type:
- Article
Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1881, doi. 10.1007/s10147-022-02247-0
- By:
- Publication type:
- Article
Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920913798
- By:
- Publication type:
- Article
p21-Activated Kinase 3 (PAK3) Is an AP-1 Regulated Gene Contributing to Actin Organisation and Migration of Transformed Fibroblasts.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066892
- By:
- Publication type:
- Article
An RNA Interference Lethality Screen of the Human Druggable Genome to Identify Molecular Vulnerabilities in Epithelial Ovarian Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047086
- By:
- Publication type:
- Article
Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical Outcome.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0030996
- By:
- Publication type:
- Article
Multi-Gene Expression Predictors of Single Drug Responses to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0030550
- By:
- Publication type:
- Article
Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0029079
- By:
- Publication type:
- Article
Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0028077
- By:
- Publication type:
- Article
Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0021121
- By:
- Publication type:
- Article
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018064
- By:
- Publication type:
- Article
Integrated Analysis of Multiple Microarray Datasets Identifies a Reproducible Survival Predictor in Ovarian Cancer.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0018202
- By:
- Publication type:
- Article
Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017617
- By:
- Publication type:
- Article
Biologic directed therapies in gynecologic oncology.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 6, p. 459, doi. 10.1007/s11912-003-0006-x
- By:
- Publication type:
- Article
Coordinate Regulation of Stress-activated Protein Kinase and Mitogen-activated Protein Kinase Cascades in the Apoptotic Actions of Ceramide and Sphingosine.
- Published in:
- Annals of the New York Academy of Sciences, 1998, v. 845, n. 1, p. 413, doi. 10.1111/j.1749-6632.1998.tb09703.x
- By:
- Publication type:
- Article
Ovarian Tumors of Low Malignant Potential: Can Molecular Biology Solve This Enigma?
- Published in:
- 2001
- By:
- Publication type:
- Editorial
Ovarian tumors of low malignant potential: Can molecular biology solve this enigma?
- Published in:
- 2001
- By:
- Publication type:
- commentary
Retinoic acid receptor ... expression and growth inhibition of gynecologic cancer cells by the...
- Published in:
- JNCI: Journal of the National Cancer Institute, 1998, v. 90, n. 8, p. 597, doi. 10.1093/jnci/90.8.597
- By:
- Publication type:
- Article
Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.
- Published in:
- Oncogene, 2004, v. 23, n. 49, p. 8065, doi. 10.1038/sj.onc.1207959
- By:
- Publication type:
- Article
AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targets.
- Published in:
- Oncogene, 2003, v. 22, n. 36, p. 5619, doi. 10.1038/sj.onc.1206644
- By:
- Publication type:
- Article
Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growth.
- Published in:
- Oncogene, 2003, v. 22, n. 18, p. 2710, doi. 10.1038/sj.onc.1206371
- By:
- Publication type:
- Article
CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.
- Published in:
- Oncogene, 2002, v. 21, n. 28, p. 4435, doi. 10.1038/sj.onc.1205542
- By:
- Publication type:
- Article
In situ detection of unexpected patterns of mutant p53 gene expression in non-small cell lung cancers.
- Published in:
- Oncogene, 2001, v. 20, n. 20, p. 2579, doi. 10.1038/sj.onc.1204351
- By:
- Publication type:
- Article
Molecular, Metabolic, and Subcellular Mapping of the Tumor Immune Microenvironment via 3D Targeted and Non-Targeted Multiplex Multi-Omics Analyses.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 846, doi. 10.3390/cancers16050846
- By:
- Publication type:
- Article
SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1777, doi. 10.3390/cancers13081777
- By:
- Publication type:
- Article
Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 766, doi. 10.3390/cancers12030766
- By:
- Publication type:
- Article
Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 668, doi. 10.3390/cancers11050668
- By:
- Publication type:
- Article
ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression.
- Published in:
- Cancers, 2018, v. 10, n. 12, p. 464, doi. 10.3390/cancers10120464
- By:
- Publication type:
- Article
curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome.
- Published in:
- Database: The Journal of Biological Databases & Curation, 2013, v. 2013, p. 1, doi. 10.1093/database/bat013
- By:
- Publication type:
- Article
CON: Patients at High Risk for Ovarian Cancer Should Not Undergo Routine Screening.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
CON: Therapy for a Patient With PlatinumSResistant/Refractory Ovarian Cancer Should Not be Selected Based on Results of an In Vitro Extreme Drug Sensitivity/Resistance Assay.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
PRO: Patients With Recurrent Ovarian Cancer Should be Treated With Antiangiogenic Agents in Combination With Chemotherapy.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Current Challenges and Future Directions in the Management of Ovarian Cancer: Proceedings of the First Global Workshop on Ovarian Cancer.
- Published in:
- Clinical Ovarian Cancer, 2010, v. 3, n. 2, p. 81, doi. 10.3816/COC.2010.n.015
- By:
- Publication type:
- Article
The Gynecologic Oncology Group Ovarian Treatment Trials With Specimen Banking and Translational Research.
- Published in:
- Clinical Ovarian Cancer, 2010, v. 3, n. 2, p. 98, doi. 10.3816/COC.2010.n.016
- By:
- Publication type:
- Article
Debate: Routine Screening for Patients at High Risk for Ovarian Cancer.
- Published in:
- Clinical Ovarian Cancer, 2009, v. 2, n. 2, p. 83, doi. 10.3816/COC.2009.n.015
- By:
- Publication type:
- Article
Getting Personal! The Treatment of Epithelial Ovarian Cancer.
- Published in:
- 2009
- By:
- Publication type:
- Editorial